Weight-loss jabs and those for diabetes linked to lower dementia risk – study

A study explored if semaglutide – sold under the brand names Wegovy, Ozempic and Rybelsus – could reduce the risk of heart attacks or stroke (Alamy/PA) - (Alamy/PA)

Weight-loss jabs and those for diabetes may be linked to a lower risk of dementia, a study suggests.

Semaglutide in particular, whose brand names include Wegovy and Ozempic, showed promise in cutting the risk of conditions that impair memory and thought processes, according to researchers.